Delayed Myelination in Infants and Young Children: Radiographic and Clinical Correlates
暂无分享,去创建一个
M R Natowicz | M. Natowicz | L A Squires | K S Krishnamoorthy | L. Squires | K. Krishnamoorthy | Kalpathy S. Krishnamoorthy
[1] R. Reynolds,et al. Disturbed myelinogenesis and recovery in hyperphenylalaninemia in rats: An immunohistochemical study , 1992, Experimental Neurology.
[2] P. Yakovlev,et al. The myelogenetic cycles of regional maturation of the brain , 1967 .
[3] J. Volpe. Brain development--normal and abnormal. , 1991, Journal of perinatal medicine.
[4] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[5] M. Tripp,et al. Plasma carnitine concentrations in cardiomyopathy patients. , 1984, Biochemical medicine.
[6] J. Valk,et al. The reflection of histology in MR imaging of Pelizaeus-Merzbacher disease. , 1989, AJNR. American journal of neuroradiology.
[7] K. Hopper,et al. Neurologic manifestations in 18q- syndrome. , 1990, American journal of medical genetics.
[8] V. Herzberg. Human T lymphocytes require lipid as either lipoprotein or nonesterified fatty acid for in vitro activation. , 1991, Immunological investigations.
[9] Howard E. Gendelman,et al. Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .
[10] K. Feingold,et al. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.
[11] E. Walter,et al. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy. , 1991, The Journal of pediatrics.
[12] D. Simpson. Neuromuscular Complications of Human Immunodeficiency Virus Infection , 1992, Seminars in neurology.
[13] A. Warrington,et al. The oligodendrocyte and its many cellular processes. , 1993, Trends in cell biology.
[14] S. Moretti,et al. Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral L‐carnitine , 1994, AIDS.
[15] N. Habib,et al. Syncytia formation in HIV‐1 infected cells is associated with an increase in cellular oleic acid , 1989, FEBS letters.
[16] J. Arenas,et al. Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy , 1993, Muscle & nerve.
[17] T. H. Newton,et al. MRI of normal brain maturation. , 1986, AJNR. American journal of neuroradiology.
[18] H. Kinney,et al. Delayed Central Nervous System Myelination in the Sudden Infant Death Syndrome , 1991, Journal of neuropathology and experimental neurology.
[19] J. Arenas,et al. Plasma carnitine insufficiency and effectiveness of L‐carnitine therapy in patients with mitochondril myopathy , 1993, Muscle & nerve.
[20] R. Shuman,et al. The neuropathology of the nonketotic and ketotic hyperglycinemias , 1978, Neurology.
[21] K. Feingold,et al. Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.
[22] T. Stein,et al. Protein and energy substrate metabolism in AIDS patients. , 1990, Metabolism: clinical and experimental.
[23] B. Brody,et al. Sequence of Central Nervous System Myelination in Human Infancy. I. An Autopsy Study of Myelination , 1987, Journal of neuropathology and experimental neurology.
[24] R. Wiggins. Myelin development and nutritional insufficiency , 1982, Brain Research Reviews.
[25] A. Pardee,et al. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. , 1993, Journal of acquired immune deficiency syndromes.
[26] V. Vullo,et al. High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients. , 1993, Immunopharmacology and immunotoxicology.
[27] K. Feingold,et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1992, The Journal of clinical endocrinology and metabolism.
[28] M. Dalakas,et al. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[29] J. Dobbing,et al. Quantitative growth and development of human brain , 1973, Archives of disease in childhood.
[30] M. Cloyd,et al. Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis. , 1988, Virology.
[31] J. Sidtis,et al. Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment , 1992, AIDS.
[32] P Evrard,et al. Formation, maturation, and disorders of white matter. , 1992, AJNR. American journal of neuroradiology.
[33] T. Schiano,et al. Reversal of apparent AIDS dementia complex following treatment with vitamin B12 , 1993, Journal of internal medicine.
[34] H. Gendelman,et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease , 1992, The Journal of experimental medicine.
[35] C R Bird,et al. MR assessment of myelination in infants and children: usefulness of marker sites. , 1989, AJNR. American journal of neuroradiology.
[36] S. Lipton. Human immunodefciency virus‐infected macrophages, gp120, and N‐methyl‐D‐ aspartate receptor‐mediated new‐otoxicity , 1993 .
[37] D. Norman,et al. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. , 1988, Radiology.
[38] H. Kinney,et al. Sequence of Central Nervous System Myelination in Human Infancy. II. Patterns of Myelination in Autopsied Infants , 1988, Journal of neuropathology and experimental neurology.
[39] M. Dalakas,et al. The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[40] L. Svennerholm,et al. Lipid and fatty acid composition of human cerebral myelin during development. , 1978, Advances in experimental medicine and biology.
[41] V. Vullo,et al. L‐carnitine deficiency in AIDS patients , 1992, AIDS.
[42] C. McArdle,et al. Developmental features of the neonatal brain: MR imaging. Part I. Gray-white matter differentiation and myelination. , 1987, Radiology.
[43] K. Woods. MEDICARE: A NEW HEALTH INSURANCE PROGRAMME FOR AUSTRALIA , 1984, The Lancet.
[44] M. Dalakas,et al. Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.
[45] I. Duncan. Abnormalities of myelination of the central nervous system associated with congenital tremor. , 1987, Journal of veterinary internal medicine.
[46] K. Hyland,et al. Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection , 1990, The Lancet.
[47] J. Bogden,et al. Micronutrient Status and Human Immunodeficiency Virus (HIV) Infection , 1990, Annals of the New York Academy of Sciences.
[48] D. Mildvan,et al. Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex , 1992, The Lancet.
[49] E. Richardson,et al. Cerebral white-matter hypoplasia. , 1977, Archives of neurology.
[50] J. Glass,et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dememtia , 1993, Annals of neurology.
[51] C. De Simone,et al. Reversibility by L-carnitine of immunosuppression induced by an emulsion of soya bean oil, glycerol and egg lecithin. , 1982, Arzneimittel-Forschung.
[52] G. Pezeshkpour,et al. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. , 1991, Human pathology.
[53] S. Dimauro,et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy , 1991, The Lancet.
[54] Paul D. Griffiths,et al. Magnetic Resonance Imaging of the Brain and Spine , 1996 .
[55] J. Benjamins,et al. Model Systems for Study of Perturbations of Myelin Metabolism , 1977 .
[56] H. E. Solberg,et al. Carnitine levels in human serum in health and disease. , 1974, Clinica chimica acta; international journal of clinical chemistry.
[57] L. Epstein,et al. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. , 1989, American journal of diseases of children.
[58] J. Uriel,et al. Changes in lipid composition of human peripheral blood lymphocytes infected by HIV. , 1991, AIDS research and human retroviruses.
[59] D. Monti,et al. Immunomodulatory properties of L-acetylcarnitine on lymphocytes from young and old humans , 1989 .
[60] E. Hogan,et al. Animal Models of Genetic Disorders of Myelin , 1984 .
[61] C. H. Chen,et al. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. , 1989, The Journal of biological chemistry.
[62] M. Mintz. Clinical comparison of adult and pediatric NeuroAIDS. , 1994, Advances in neuroimmunology.
[63] K. Feingold,et al. In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. , 1992, Endocrinology.
[64] W. Gahl,et al. Zidovudine‐induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage , 1994, Annals of neurology.
[65] H. Gendelman,et al. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms , 1993, Annals of neurology.